Hip Products - DePuy

Scharf v. Depuy Orthopaedics et al

Nova Scotia Supreme Court File: Hfx No. 342055  

On January 11, 2011 Wagners, in cooperation with Stevensons LLP of Toronto, Ontario, filed a proposed class proceeding in the Supreme Court of Nova Scotia on behalf of residents of Nova Scotia who were implanted with a DePuy Hip Implant at any time between July 2003 to the date of certification of the lawsuit as a class proceeding.

DePuy implants were developed in order to reconstruct human hip joints that are diseased due to conditions such as osteoarthritis, rheumatoid arthritis, avascular necrosis, or fracture. The DePuy implants are designed to replace all or parts of diseased hip joints in order to alleviate symptoms of these health conditions. They are designed to last for an average of 15 or more years. The Defendants aggressively marketed the DePuy implants as having advantages over other hip replacement or resurfacing systems and they were advertised as suitable, safe, effective, minimally invasive hip replacements, and as "high performance" systems.

It is alleged that for at least two years the Defendants knew, contrary to their marketing campaigns, that a disproportionately high number of DePuy implants were failing and causing harm to patients. Complaints to Health Canada and the US FDA included component loosening, misalignment, dislocation and fracture, and the creation of abnormal or excessive metal debris in the hip socket. This metal debris could spread to surrounding tissue, causing severe inflammation and damage. The failure of the DePuy implants often requires complicated, expensive and painful revision surgery to correct.

The Defendants were also aware that the Australian Joint Registry had issued seven reports to the Defendants or their Australian affiliates starting in 2007 that identified problems with the DePuy implants. The Defendants withdrew the DePuy implants from the Australian market in December 2009, however, they consistently failed to disclose or warn Canadian patients of the significant risk of failure in the DePuy implants. The Defendants knew or ought to have known of the significant risks associated with the use of DePuy implants.

The following documents concerning the class action which Wagners has filed in relation to the defective DePuy hip implant product manufactured by Johnson & Johnson are available for viewing in PDF format:

Wagners is presently accepting enquiries from residents of Nova Scotia and New Brunswick who have suffered adverse effects, debilitating injuries or permanent disability as a result of being fitted with a defective and faulty DePuy hip omplant.

If you, or a member of your family, have suffered problems or issues with the implant, or were required to have the device explanted as a result of the DePuy hip implant and injury or other losses have resulted, you may be eligible for inclusion as a Class Member in the proposed class action lawsuits.

To sign up and determine if you qualify, please fill out this registration form:

Top Ten Award Canadian Lawyer Magazine Lexpert ranking logo